Prandin (Repaglinide) clinical pharmacology - prescription drugs and medications at RxList

Find a Drug Advanced Search

Professional

Consumer

« Previous
Clinical Pharmacology
Next »

Prandin

Clinical Pharmacology

font size

Clinical Pharmacology

Prandin

¹: based on intent-to-treat analysis
^*: p-value 0.001 for comparison to either monotherapy
^#: p-value £ 0.001 for comparison to PRANDIN
Final median doses: rosiglitazone - 4 mg/day for combination and 8 mg/day for monotherapy; PRANDIN - 6 mg/day for combination and 12 mg/day for monotherapy

Brand Name: Prandin
Generic Name: Repaglinide

« Previous
Clinical Pharmacology
Next »

Next: Prandin - Patient Information »
« Previous: Prandin - Overdosage & Contraindications

Bookmark this page:

WebMD Resources

Living with an Insulin Pump
After years of debilitating seizures, diabetic Melissa Jeffries regains control of her diabetes through the use of an insulin pump. See more WebMD Videos »